vs
滨特尔（PNR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是滨特尔的1.4倍（$1.4B vs $1.0B），瑞思迈净利率更高（27.6% vs 16.6%，领先11.0%），瑞思迈同比增速更快（11.0% vs 2.6%），瑞思迈自由现金流更多（$311.2M vs $-85.7M），过去两年瑞思迈的营收复合增速更高（9.0% vs -2.9%）
滨特尔（股票代码PNR）是知名水处理企业，注册地位于爱尔兰，税务居民身份归属英国，美国区总部设于明尼苏达州金谷市。品牌起源于美国，2017年数据显示其65%的营收来自美国和加拿大，2014年集团完成架构重组，注册地由瑞士变更为爱尔兰。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
PNR vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$1.0B
营收增速更快
RMD
高出8.4%
2.6%
净利率更高
RMD
高出11.0%
16.6%
自由现金流更多
RMD
多$396.9M
$-85.7M
两年增速更快
RMD
近两年复合增速
-2.9%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $172.4M | $392.6M |
| 毛利率 | 41.8% | 61.8% |
| 营业利润率 | 20.3% | 34.6% |
| 净利率 | 16.6% | 27.6% |
| 营收同比 | 2.6% | 11.0% |
| 净利润同比 | 11.3% | 13.9% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PNRRMD
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $972.9M | $1.3B | ||
| Q3 24 | $993.4M | $1.2B | ||
| Q2 24 | $1.1B | $1.2B |
净利润PNRRMD
| Q1 26 | $172.4M | — | ||
| Q4 25 | $166.1M | $392.6M | ||
| Q3 25 | $184.3M | $348.5M | ||
| Q2 25 | $148.5M | $379.7M | ||
| Q1 25 | $154.9M | $365.0M | ||
| Q4 24 | $166.4M | $344.6M | ||
| Q3 24 | $139.6M | $311.4M | ||
| Q2 24 | $186.1M | $292.2M |
毛利率PNRRMD
| Q1 26 | 41.8% | — | ||
| Q4 25 | 40.4% | 61.8% | ||
| Q3 25 | 41.0% | 61.5% | ||
| Q2 25 | 40.7% | 60.8% | ||
| Q1 25 | 39.9% | 59.3% | ||
| Q4 24 | 38.8% | 58.6% | ||
| Q3 24 | 39.6% | 58.6% | ||
| Q2 24 | 39.8% | 58.5% |
营业利润率PNRRMD
| Q1 26 | 20.3% | — | ||
| Q4 25 | 20.1% | 34.6% | ||
| Q3 25 | 22.7% | 33.4% | ||
| Q2 25 | 19.4% | 33.7% | ||
| Q1 25 | 20.1% | 33.0% | ||
| Q4 24 | 20.1% | 32.5% | ||
| Q3 24 | 18.1% | 31.6% | ||
| Q2 24 | 22.6% | 31.2% |
净利率PNRRMD
| Q1 26 | 16.6% | — | ||
| Q4 25 | 16.3% | 27.6% | ||
| Q3 25 | 18.0% | 26.1% | ||
| Q2 25 | 13.2% | 28.2% | ||
| Q1 25 | 15.3% | 28.3% | ||
| Q4 24 | 17.1% | 26.9% | ||
| Q3 24 | 14.1% | 25.4% | ||
| Q2 24 | 16.9% | 23.9% |
每股收益（稀释后）PNRRMD
| Q1 26 | — | — | ||
| Q4 25 | $1.01 | $2.68 | ||
| Q3 25 | $1.12 | $2.37 | ||
| Q2 25 | $0.90 | $2.58 | ||
| Q1 25 | $0.93 | $2.48 | ||
| Q4 24 | $0.99 | $2.34 | ||
| Q3 24 | $0.84 | $2.11 | ||
| Q2 24 | $1.11 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.7M | $1.4B |
| 总债务越低越好 | $1.9B | $403.9M |
| 股东权益账面价值 | $3.8B | $6.3B |
| 总资产 | $7.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.51× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资PNRRMD
| Q1 26 | $67.7M | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $128.4M | $1.4B | ||
| Q2 25 | $143.0M | $1.2B | ||
| Q1 25 | $140.6M | $932.7M | ||
| Q4 24 | $118.7M | $521.9M | ||
| Q3 24 | $218.1M | $426.4M | ||
| Q2 24 | $214.3M | $238.4M |
总债务PNRRMD
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.6B | $403.9M | ||
| Q3 25 | $1.6B | $408.7M | ||
| Q2 25 | $1.4B | $658.4M | ||
| Q1 25 | $1.8B | $663.1M | ||
| Q4 24 | $1.6B | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | $1.8B | $697.3M |
股东权益PNRRMD
| Q1 26 | $3.8B | — | ||
| Q4 25 | $3.9B | $6.3B | ||
| Q3 25 | $3.8B | $6.1B | ||
| Q2 25 | $3.7B | $6.0B | ||
| Q1 25 | $3.6B | $5.5B | ||
| Q4 24 | $3.6B | $5.3B | ||
| Q3 24 | $3.5B | $5.2B | ||
| Q2 24 | $3.4B | $4.9B |
总资产PNRRMD
| Q1 26 | $7.1B | — | ||
| Q4 25 | $6.9B | $8.5B | ||
| Q3 25 | $6.8B | $8.3B | ||
| Q2 25 | $6.5B | $8.2B | ||
| Q1 25 | $6.7B | $7.6B | ||
| Q4 24 | $6.4B | $7.1B | ||
| Q3 24 | $6.5B | $7.2B | ||
| Q2 24 | $6.5B | $6.9B |
负债/权益比PNRRMD
| Q1 26 | 0.51× | — | ||
| Q4 25 | 0.42× | 0.06× | ||
| Q3 25 | 0.42× | 0.07× | ||
| Q2 25 | 0.38× | 0.11× | ||
| Q1 25 | 0.51× | 0.12× | ||
| Q4 24 | 0.46× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | 0.51× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-85.7M | $311.2M |
| 自由现金流率自由现金流/营收 | -8.3% | 21.9% |
| 资本支出强度资本支出/营收 | 1.8% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $716.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流PNRRMD
| Q1 26 | — | — | ||
| Q4 25 | $50.8M | $339.7M | ||
| Q3 25 | $196.3M | $457.3M | ||
| Q2 25 | $606.6M | $538.8M | ||
| Q1 25 | $-38.9M | $578.7M | ||
| Q4 24 | $86.5M | $308.6M | ||
| Q3 24 | $248.6M | $325.5M | ||
| Q2 24 | $539.2M | $440.1M |
自由现金流PNRRMD
| Q1 26 | $-85.7M | — | ||
| Q4 25 | $27.1M | $311.2M | ||
| Q3 25 | $178.9M | $414.4M | ||
| Q2 25 | $595.7M | $508.2M | ||
| Q1 25 | $-55.7M | $557.9M | ||
| Q4 24 | $63.8M | $288.0M | ||
| Q3 24 | $233.2M | $307.7M | ||
| Q2 24 | $522.2M | $415.2M |
自由现金流率PNRRMD
| Q1 26 | -8.3% | — | ||
| Q4 25 | 2.7% | 21.9% | ||
| Q3 25 | 17.5% | 31.0% | ||
| Q2 25 | 53.0% | 37.7% | ||
| Q1 25 | -5.5% | 43.2% | ||
| Q4 24 | 6.6% | 22.5% | ||
| Q3 24 | 23.5% | 25.1% | ||
| Q2 24 | 47.5% | 33.9% |
资本支出强度PNRRMD
| Q1 26 | 1.8% | — | ||
| Q4 25 | 2.3% | 2.0% | ||
| Q3 25 | 1.7% | 3.2% | ||
| Q2 25 | 1.0% | 2.3% | ||
| Q1 25 | 1.7% | 1.6% | ||
| Q4 24 | 2.3% | 1.6% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 1.5% | 2.0% |
现金转化率PNRRMD
| Q1 26 | — | — | ||
| Q4 25 | 0.31× | 0.87× | ||
| Q3 25 | 1.07× | 1.31× | ||
| Q2 25 | 4.08× | 1.42× | ||
| Q1 25 | -0.25× | 1.59× | ||
| Q4 24 | 0.52× | 0.90× | ||
| Q3 24 | 1.78× | 1.05× | ||
| Q2 24 | 2.90× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PNR
| Water Solutions | $391.0M | 38% |
| Pool | $387.1M | 37% |
| Flow | $258.1M | 25% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
